BioCentury
ARTICLE | Company News

LabCorp, Verastem deal

January 21, 2013 8:00 AM UTC

Verastem partnered with LabCorp to validate biomarkers for a companion diagnostic for Verastem's VS-6063. The partners will evaluate the biomarkers in clinical trials with VS-6063 for ovarian cancer ...